JCR Pharmaceuticals sales and marketing update

JCR launched Temcell HS ( JR-031) in Japan to treat acute graft-versus-host disease (GvHD). The companies said the product, which comprises allogeneic adult mesenchymal precursor cells (MPCs), is the...